Peer Reviewed Medical Papers Submitted To Various Medical Journals, Evidencing A Multitude Of Adverse Events In Covid-19 Vaccine Recipients
(includes terms: Inflammatory Heart Reactions & Myocardial)
An inflammation of the heart muscle (myocardium). The inflammation can reduce the
heart’s ability to pump and cause rapid or irregular heart rhythms (arrhythmias). Signs and
symptoms of myocarditis include chest pain, fatigue, shortness of breath, and rapid or
irregular heartbeats. In a small percentage of cases persons with myocarditis can be at
risk of sudden death following strenuous activity. Some sufferers of myocarditis may
require heart surgery or a heart transplant later in life.
- Myocarditis after mRNA vaccination against SARS-CoV-2, a case series: https://
www.sciencedirect.com/science/article/pii/S2666602221000409 - Myocarditis after immunization with COVID-19 mRNA vaccines in members of the
US military. This article reports that in “23 male patients, including 22 previously
healthy military members, myocarditis was identified within 4 days after receipt of the
vaccine”: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601 - Association of myocarditis with the BNT162b2 messenger RNA COVID-19 vaccine
in a case series of children: https://pubmed.ncbi.nlm.nih.gov/34374740/ - Acute symptomatic myocarditis in seven adolescents after Pfizer-BioNTech
COVID-19 vaccination: https://pediatrics.aappublications.org/content/early/
2021/06/04/peds.2021-052478 - Myocarditis and pericarditis after vaccination with COVID-19 mRNA: practical
considerations for care providers: https://www.sciencedirect.com/science/article/pii/
S0828282X21006243 - Myocarditis, pericarditis and cardiomyopathy after COVID-19 vaccination: https://
www.sciencedirect.com/science/article/pii/S1443950621011562 - Myocarditis with COVID-19 mRNA vaccines: https://www.ahajournals.org/doi/pdf/
10.1161/CIRCULATIONAHA.121.056135 - Myocarditis and pericarditis after COVID-19 vaccination: https://jamanetwork.com/
journals/jama/fullarticle/2782900 - Myocarditis temporally associated with COVID-19 vaccination: https://
www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891. - COVID-19 Vaccination Associated with Myocarditis in Adolescents: https://
pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.
2021-053427.full.pdf - Acute myocarditis after administration of BNT162b2 vaccine against COVID-19:
https://pubmed.ncbi.nlm.nih.gov/33994339/ - Temporal association between COVID-19 vaccine Ad26.COV2.S and acute
myocarditis: case report and review of the literature: https://www.sciencedirect.com/
science/article/pii/S1553838921005789 - COVID-19 vaccine-induced myocarditis: a case report with review of the literature:
https://www.sciencedirect.com/science/article/pii/S1871402121002253
Myocarditis (includes terms: Inflammatory Heart Reactions & Myocardial)
An inflammation of the heart muscle (myocardium). The inflammation can reduce the
heart’s ability to pump and cause rapid or irregular heart rhythms (arrhythmias). Signs and
symptoms of myocarditis include chest pain, fatigue, shortness of breath, and rapid or
irregular heartbeats. In a small percentage of cases persons with myocarditis can be at
risk of sudden death following strenuous activity. Some sufferers of myocarditis may
require heart surgery or a heart transplant later in life. - Potential association between COVID-19 vaccine and myocarditis: clinical and CMR
findings: https://www.sciencedirect.com/science/article/pii/S1936878X2100485X - Recurrence of acute myocarditis temporally associated with receipt of coronavirus
mRNA disease vaccine 2019 (COVID-19) in a male adolescent: https://
www.sciencedirect.com/science/article/pii/S002234762100617X - Fulminant myocarditis and systemic hyper inflammation temporally associated with
BNT162b2 COVID-19 mRNA vaccination in two patients: https://
www.sciencedirect.com/science/article/pii/S0167527321012286. - Acute myocarditis after administration of BNT162b2 vaccine: https://
www.sciencedirect.com/science/article/pii/S2214250921001530 - Lymphohistocytic myocarditis after vaccination with COVID-19 Ad26.COV2.S viral
vector: https://www.sciencedirect.com/science/article/pii/S2352906721001573 - Myocarditis following vaccination with BNT162b2 in a healthy male: https://
www.sciencedirect.com/science/article/pii/S0735675721005362 - Acute myocarditis after Comirnaty (Pfizer) vaccination in a healthy male with
previous SARS-CoV-2 infection: https://www.sciencedirect.com/science/article/pii/
S1930043321005549 - Acute myocarditis after vaccination with SARS-CoV-2 mRNA-1273 mRNA: https://
www.sciencedirect.com/science/article/pii/S2589790X21001931 - Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man: https://
www.sciencedirect.com/science/article/pii/S0870255121003243 - A series of patients with myocarditis after vaccination against SARS-CoV-2 with
mRNA-1279 and BNT162b2: https://www.sciencedirect.com/science/article/pii/
S1936878X21004861 - COVID-19 mRNA vaccination and myocarditis: https://pubmed.ncbi.nlm.nih.gov/
34268277/ - COVID-19 vaccine and myocarditis: https://pubmed.ncbi.nlm.nih.gov/34399967/
- Epidemiology and clinical features of myocarditis/pericarditis before the introduction
of COVID-19 mRNA vaccine in Korean children: a multicenter study https://
search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resourc e/en/
covidwho-1360706. - COVID-19 vaccines and myocarditis: https://pubmed.ncbi.nlm.nih.gov/34246566/
- Myocarditis and other cardiovascular complications of COVID-19 mRNA-based
COVID-19 vaccines https://www.cureus.com/articles/61030-myocarditis-and-othercardiovascular-
complications-of-the-mrna-based-covid-19-vaccines - Myocarditis and other cardiovascular complications of COVID-19 mRNA-based
COVID-19 vaccines https://www.cureus.com/articles/61030-myocarditis-and-othercardiovascular-
complications-of-the-mrna-based-covid-19-vaccines - Myocarditis, pericarditis, and cardiomyopathy after COVID-19 vaccination: https://
pubmed.ncbi.nlm.nih.gov/34340927/ - Myocarditis with covid-19 mRNA vaccines: https://www.ahajournals.org/doi/10.1161/
CIRCULATIONAHA.121.056135
(TO BE CONTINUED)
